Farsin Yadegardjam

GENEART AG provides integrated system solutions for DNA engineering focusing on gene synthesis, evolution and plasmid services. The company provides the technologies for pharmaceutical and biotechnology companies, chemical industry and universities for the development and production of new bio therapeutics, vaccines and improved industrial enzymes. Its service portfolio is comprised of 4 fields of business, which range from the production of synthetic genes and the generation of gene variants/gene libraries in combinatorial biology right through to the production of plasmid DNA. The company was founded by Ralf Wagner and Marcus Graf in 1999 and is headquartered in Regensburg, Germany.

EVP Capital Management AG (EVP) is the venture capital arm of Switzerland-based Co-Investor AG. Formerly known as equinet Venture Partners, the firm was formally established in 1998 and is located in Frankfurt. EVP manages venture capital funds including the EAP Start-Fonds sponsored by the government-controlled KfW Bankengruppe, and the VRP fund (Venture Capital Rheinland-Pfalz) sponsored by the regional development agency ISB-Investitions- und Strukturbank Rheinland-Pfalz and by the regional bank Landesbank Rheinland-Pfalz, as well as by leading insurance companies and corporations. EVP is also active in the secondary market. In 2004 the firm took over the management of Heptagon Capital Beteiligungsgesellschaft der Freien Sparkassen mbH on behalf of the seven independent German savings banks.

Nanogate SE develops and produces nano composites and formulations. The company was founded by Ralf-Michael Zastrau in 1999 and is headquartered in Goettelborn, Germany.

Fixatti Holding AG engages in the acquisition, management, and disposal of participating interests in firms in the trade, services, and industrial sectors, particularly in the field of adhesive technologies. The company was founded on May 10, 2005 and is headquartered in Wallisellen, Switzerland.

Signature Diagnostics AG operates as a molecular diagnostics company. It discovers, validates and develops novel diagnostic products that predict outcome and drug response in patients with colorectal cancer, non-small cell lung cancer and ovarian cancer. The company was founded by André Rosenthal in 2004 and is headquartered in Potsdam, Germany.

Phenex Pharmaceuticals AG engages in the research and development of small molecule drugs focusing on the identification and analysis of selective drug candidates that target nuclear receptors. It also offers its resources and capabilities in the field of nuclear receptors to customers in the pharmaceutical and other life science industries. The company was founded by Claus Kremoser in 2002 and is headquartered in Ludwigshafen, Germany.

COI Partners AG (COI Partners) is a private equity firm founded in 2000. The firm is headquartered in Zurich.

K & K Group AG operates as a holding Swiss company. The private company is based in Zug, CH. and has subsidiaries in Switzerland, United Kingdom and Germany.

Tranquini GmbH engages in the manufacture and distribution of natural ingredient beverages. The company was founded by Ahmed Elafifi in April 2015 and is headquartered in Vienna, Austria.